| GBP millions | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 1.1 | 0.9 | 0.6 | 0.6 | 0.6 | 0.6 | +9.6% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 2.1 | 1.5 | 1.2 | 3.9 | 2.9 | 1.0 | −65.6% | |
| Operating income | (3.4) | (1.5) | (1.0) | (1.1) | (0.9) | (1.0) | −3.0% | |
| Interest expense | 0.4 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.9 | 0.8 | 0.0 | 0.8 | 0.5 | 0.0 | −100.0% | |
| Other income / expense | (2.4) | 0.9 | (3.4) | (4.2) | (2.7) | (1.3) | +53.8% | |
| Pre-tax income | (5.8) | (0.6) | (4.4) | (5.3) | (3.7) | (2.2) | +39.2% | |
| Income tax | 1.7 | (2.5) | 1.4 | 2.4 | 1.6 | (0.7) | −142.6% | |
| Net income | (7.5) | 1.9 | (4.4) | (5.3) | (3.7) | (2.2) | +39.2% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.01) | 0.00 | (0.01) | (0.01) | (0.01) | (0.00) | +69.6% | |
| EPS, diluted (per share) | (0.01) | 0.00 | (0.01) | (0.01) | (0.01) | (0.00) | +69.6% | |
| EBITDA | (5.4) | 2.2 | (2.3) | (2.0) | 0.0 | (0.3) | — | |
| Depreciation & amortization | 0.0 | 1.5 | 0.7 | 0.9 | 0.0 | 2.6 | — | |
| Weighted average shares (shares) | 561,388,000 | 561,388,000 | 561,388,000 | 561,388,000 | 561,388,000 | 561,388,000 | +0.0% | |
| Weighted average diluted shares (shares) | 561,388,000 | 561,388,000 | 561,388,000 | 561,388,000 | 561,388,000 | 561,388,000 | +0.0% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
